Anatara Lifesciences Ltd Information

Anatara Lifesciences is developing evidence-based solutions for gastrointestinal diseases in humans and animals. GaRP is the working name for Anatara’s evidence based complementary medicines using unique formulations of bromelain, an enzyme extracted from pineapple stems along with other synergistic GRAS components. The combination and coating of these GaRP components have a beneficial effect on the physiology of the gastrointestinal lining, a positive influence on the microbiome (homeostasis & metabolites) and allows absorption of components in targeted areas of the gastrointestinal tract. GaRP’s multimodal activity provides a versatility for tailoring the components to various indications. Human Applications GaRP's human formulation is a microbiome-targeted multi-component complementary medicine that has been designed to address the primary underlying factors associated with gastrointestinal disorders such as IBS and IBD. Our formulation is positioned as an adjunct to existing therapies and is currently being tested in a double-blinded, placebo-controlled human clinical trial for safety and efficacy. For further information on our human development plans, visit our webpage: https://anataralifesciences.com/products-pipeline/human-applications/. Animal Applications Anatara developed Detach® for the control of scour (diarrhoea) in pigs which was approved the Australian Pesticides and Veterinary Medicines Authority (APVMA). Detach® has been shown to reduce post-weaning diarrhoea and provide similar protection to antimicrobial agents, such as zinc oxide. BONIFF is a revised formulation of Detach® that can be applied to dry feed for piglets after weaning for a simplified feeding process. ANR-pf is a proprietary enriched formulation for poultry in water, providing a quick and flexible dosing method on-farm. For further information on our Detach® development plans, visit our webpage: https://anataralifesciences.com/products-pipeline/animal-applications/.